Literature DB >> 1115906

Proceedings: Operative mortality and postoperative morbidity of highly selective vagotomy.

D Johnston.   

Abstract

Mesh:

Year:  1975        PMID: 1115906     DOI: 10.1002/bjs.1800621226

Source DB:  PubMed          Journal:  Br J Surg        ISSN: 0007-1323            Impact factor:   6.939


× No keyword cloud information.
  8 in total

1.  Gastric emptying for solids in patients with duodenal ulcer before and after highly selective vagotomy.

Authors:  W Mistiaen; R Van Hee; P Blockx; A Hubens
Journal:  Dig Dis Sci       Date:  1990-03       Impact factor: 3.199

Review 2.  Iatrogenic problems following gastric surgery.

Authors:  B S Jay; M Burrell
Journal:  Gastrointest Radiol       Date:  1977-12-20

3.  Surgical prophylaxis of gastroduodenal complications associated with renal allotransplantation.

Authors:  G Uhlschmid; F Largiadèr
Journal:  World J Surg       Date:  1977-05       Impact factor: 3.352

Review 4.  Current status of parietal cell vagotomy.

Authors:  P H Jordan
Journal:  Ann Surg       Date:  1976-12       Impact factor: 12.969

5.  Arterial vascularization of the operated stomach: highly selective vagotomy, anterior lesser curve seromyotomy, esophageal replacement by transposed stomach after esophagectomy or circular pharyngolaryngectomy.

Authors:  A K Agossou-Voyème; J Hureau; M Germain
Journal:  Surg Radiol Anat       Date:  1990       Impact factor: 1.246

6.  The surgical treatment of peptic ulcer disease. A physician's view.

Authors:  J P Bader
Journal:  Dig Dis Sci       Date:  1985-11       Impact factor: 3.199

7.  Recurrences 1 to 10 years after highly selective vagotomy in prepyloric and duodenal ulcer disease. Frequency, pattern, and predictors.

Authors:  H O Adami; L K Enander; L Enskog; C Ingvar; B Rydberg
Journal:  Ann Surg       Date:  1984-04       Impact factor: 12.969

8.  Peptic ulcer disease and thoracoscopic left truncal vagotomy.

Authors:  E Croce; S Olmi; R Russo; M Azzola; E Mastropasqua
Journal:  JSLS       Date:  1999 Jul-Sep       Impact factor: 2.172

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.